In conclusion, this investigation sheds light on a robust association between CYP1A2 gene polymorphisms, particularly the − 163 C/A allele, and an increased susceptibility to bladder cancer (BLCA). This evidence concerns the gene CYP1A2 and urinary bladder cancer.